Intact parathyroid hormone: Performance and clinical utility of an automated assay based on high-performance immunoaffinity chromatography and chemiluminescence detection

D. S. Hage, B. Taylor, P. C. Kao

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The performance and clinical utility of an automated assay of intact parathyroid hormone (parathyrin, PTH) are evaluated. The method is based on the extraction of PTH from plasma by an HPLC column containing immobilized anti-(44-68 PTH) antibodies. The PTH retained is detected with a postcolumn reactor and use of anti-(1-34 PTH) chemiluminescent-labeled antibodies. The total cycle time of the assay is 6.5 min per injection after a 1-h incubation. The lower limit of detection for PTH in a 66-μL plasma sample was 0.5 pmol/L based on peak heights and 0.2 pmol/L based on peak areas. Mean analytical recovery for PTH added to plasma was 97%. The within-day precisions (CVs) for 4.2 and 30 pmol/L PTH plasma samples were 9.2% and 5.6% and the day-to-day precisions were 10.3% and 5.7%, respectively. No significant interferences from 1-34, 44-68, or 53-84 PTH fragments were noted, even at highly increased concentrations of fragments. The correlation of results with those of a manual assay of intact PTH was 0.97, and the results showed good agreement with disease state for patients with hypo- or hyperparathyroidism. The specificity of the assay for primary hyperparathyroidism was >95%. We discuss the advantages (speed and quality control) of this approach over current immunoassays and the potential use of this method for detecting other analytes.

Original languageEnglish (US)
Pages (from-to)1494-1500
Number of pages7
JournalClinical Chemistry
Volume38
Issue number8 Part 1
StatePublished - Jan 1 1992

Fingerprint

Chemiluminescence
Chromatography
Luminescence
Parathyroid Hormone
Assays
Plasmas
Hypoparathyroidism
Primary Hyperparathyroidism
Antibodies
Hyperparathyroidism
Speed control
Immunoassay
Quality Control
Quality control
Limit of Detection
High Pressure Liquid Chromatography
Recovery
Injections

Keywords

  • chronic renal failure
  • hypercalcemia of malignancy
  • hyperparathyroidism

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Intact parathyroid hormone : Performance and clinical utility of an automated assay based on high-performance immunoaffinity chromatography and chemiluminescence detection. / Hage, D. S.; Taylor, B.; Kao, P. C.

In: Clinical Chemistry, Vol. 38, No. 8 Part 1, 01.01.1992, p. 1494-1500.

Research output: Contribution to journalArticle

@article{884b6feb6d0846dab7e8db8953644824,
title = "Intact parathyroid hormone: Performance and clinical utility of an automated assay based on high-performance immunoaffinity chromatography and chemiluminescence detection",
abstract = "The performance and clinical utility of an automated assay of intact parathyroid hormone (parathyrin, PTH) are evaluated. The method is based on the extraction of PTH from plasma by an HPLC column containing immobilized anti-(44-68 PTH) antibodies. The PTH retained is detected with a postcolumn reactor and use of anti-(1-34 PTH) chemiluminescent-labeled antibodies. The total cycle time of the assay is 6.5 min per injection after a 1-h incubation. The lower limit of detection for PTH in a 66-μL plasma sample was 0.5 pmol/L based on peak heights and 0.2 pmol/L based on peak areas. Mean analytical recovery for PTH added to plasma was 97{\%}. The within-day precisions (CVs) for 4.2 and 30 pmol/L PTH plasma samples were 9.2{\%} and 5.6{\%} and the day-to-day precisions were 10.3{\%} and 5.7{\%}, respectively. No significant interferences from 1-34, 44-68, or 53-84 PTH fragments were noted, even at highly increased concentrations of fragments. The correlation of results with those of a manual assay of intact PTH was 0.97, and the results showed good agreement with disease state for patients with hypo- or hyperparathyroidism. The specificity of the assay for primary hyperparathyroidism was >95{\%}. We discuss the advantages (speed and quality control) of this approach over current immunoassays and the potential use of this method for detecting other analytes.",
keywords = "chronic renal failure, hypercalcemia of malignancy, hyperparathyroidism",
author = "Hage, {D. S.} and B. Taylor and Kao, {P. C.}",
year = "1992",
month = "1",
day = "1",
language = "English (US)",
volume = "38",
pages = "1494--1500",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "8 Part 1",

}

TY - JOUR

T1 - Intact parathyroid hormone

T2 - Performance and clinical utility of an automated assay based on high-performance immunoaffinity chromatography and chemiluminescence detection

AU - Hage, D. S.

AU - Taylor, B.

AU - Kao, P. C.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - The performance and clinical utility of an automated assay of intact parathyroid hormone (parathyrin, PTH) are evaluated. The method is based on the extraction of PTH from plasma by an HPLC column containing immobilized anti-(44-68 PTH) antibodies. The PTH retained is detected with a postcolumn reactor and use of anti-(1-34 PTH) chemiluminescent-labeled antibodies. The total cycle time of the assay is 6.5 min per injection after a 1-h incubation. The lower limit of detection for PTH in a 66-μL plasma sample was 0.5 pmol/L based on peak heights and 0.2 pmol/L based on peak areas. Mean analytical recovery for PTH added to plasma was 97%. The within-day precisions (CVs) for 4.2 and 30 pmol/L PTH plasma samples were 9.2% and 5.6% and the day-to-day precisions were 10.3% and 5.7%, respectively. No significant interferences from 1-34, 44-68, or 53-84 PTH fragments were noted, even at highly increased concentrations of fragments. The correlation of results with those of a manual assay of intact PTH was 0.97, and the results showed good agreement with disease state for patients with hypo- or hyperparathyroidism. The specificity of the assay for primary hyperparathyroidism was >95%. We discuss the advantages (speed and quality control) of this approach over current immunoassays and the potential use of this method for detecting other analytes.

AB - The performance and clinical utility of an automated assay of intact parathyroid hormone (parathyrin, PTH) are evaluated. The method is based on the extraction of PTH from plasma by an HPLC column containing immobilized anti-(44-68 PTH) antibodies. The PTH retained is detected with a postcolumn reactor and use of anti-(1-34 PTH) chemiluminescent-labeled antibodies. The total cycle time of the assay is 6.5 min per injection after a 1-h incubation. The lower limit of detection for PTH in a 66-μL plasma sample was 0.5 pmol/L based on peak heights and 0.2 pmol/L based on peak areas. Mean analytical recovery for PTH added to plasma was 97%. The within-day precisions (CVs) for 4.2 and 30 pmol/L PTH plasma samples were 9.2% and 5.6% and the day-to-day precisions were 10.3% and 5.7%, respectively. No significant interferences from 1-34, 44-68, or 53-84 PTH fragments were noted, even at highly increased concentrations of fragments. The correlation of results with those of a manual assay of intact PTH was 0.97, and the results showed good agreement with disease state for patients with hypo- or hyperparathyroidism. The specificity of the assay for primary hyperparathyroidism was >95%. We discuss the advantages (speed and quality control) of this approach over current immunoassays and the potential use of this method for detecting other analytes.

KW - chronic renal failure

KW - hypercalcemia of malignancy

KW - hyperparathyroidism

UR - http://www.scopus.com/inward/record.url?scp=0026726827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026726827&partnerID=8YFLogxK

M3 - Article

C2 - 1643722

AN - SCOPUS:0026726827

VL - 38

SP - 1494

EP - 1500

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 8 Part 1

ER -